These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Immunoprofiles and DNA Methylation of Inflammatory Marker Genes in Ulcerative Colitis-Associated Colorectal Tumorigenesis. Mäki-Nevala S; Ukwattage S; Wirta EV; Ahtiainen M; Ristimäki A; Seppälä TT; Lepistö A; Mecklin JP; Peltomäki P Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680073 [TBL] [Abstract][Full Text] [Related]
4. Implication of DNA repair genes in Lynch-like syndrome. Xicola RM; Clark JR; Carroll T; Alvikas J; Marwaha P; Regan MR; Lopez-Giraldez F; Choi J; Emmadi R; Alagiozian-Angelova V; Kupfer SS; Ellis NA; Llor X Fam Cancer; 2019 Jul; 18(3):331-342. PubMed ID: 30989425 [TBL] [Abstract][Full Text] [Related]
5. Recent discoveries in the molecular genetics of Lynch syndrome. Boland CR Fam Cancer; 2016 Jul; 15(3):395-403. PubMed ID: 27038793 [TBL] [Abstract][Full Text] [Related]
6. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639 [TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
8. Epidemiological, clinical and molecular characterization of Lynch-like syndrome: A population-based study. Porkka N; Lahtinen L; Ahtiainen M; Böhm JP; Kuopio T; Eldfors S; Mecklin JP; Seppälä TT; Peltomäki P Int J Cancer; 2019 Jul; 145(1):87-98. PubMed ID: 30575961 [TBL] [Abstract][Full Text] [Related]
9. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway. Kim JH; Bae JM; Cho NY; Kang GH Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113 [TBL] [Abstract][Full Text] [Related]
10. Assessment of Tumor Sequencing as a Replacement for Lynch Syndrome Screening and Current Molecular Tests for Patients With Colorectal Cancer. Hampel H; Pearlman R; Beightol M; Zhao W; Jones D; Frankel WL; Goodfellow PJ; Yilmaz A; Miller K; Bacher J; Jacobson A; Paskett E; Shields PG; Goldberg RM; de la Chapelle A; Shirts BH; Pritchard CC; JAMA Oncol; 2018 Jun; 4(6):806-813. PubMed ID: 29596542 [TBL] [Abstract][Full Text] [Related]
11. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques. Deycmar S; Johnson BJ; Ray K; Schaaf GW; Ryan DP; Cullin C; Dozier BL; Ferguson B; Bimber BN; Olson JD; Caudell DL; Whitlow CT; Solingapuram Sai KK; Romero EC; Villinger FJ; Burgos AG; Ainsworth HC; Miller LD; Hawkins GA; Chou JW; Gomes B; Hettich M; Ceppi M; Charo J; Cline JM J Transl Med; 2024 Mar; 22(1):292. PubMed ID: 38504345 [TBL] [Abstract][Full Text] [Related]
12. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
13. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related]
15. Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade. Wang T; Lee LH; Vyas M; Zhang L; Ganesh K; Firat C; Segal NH; Desai A; Hechtman JF; Ntiamoah P; Weiser MR; Markowitz AJ; Vakiani E; Klimstra DS; Stadler ZK; Shia J Mod Pathol; 2019 Oct; 32(10):1551-1562. PubMed ID: 31175329 [TBL] [Abstract][Full Text] [Related]
16. The dynamic DNA methylation landscape of the Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327 [TBL] [Abstract][Full Text] [Related]
17. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350 [TBL] [Abstract][Full Text] [Related]
18. Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment. Rigter LS; Snaebjornsson P; Rosenberg EH; Atmodimedjo PN; Aleman BM; Ten Hoeve J; Geurts-Giele WR; ; van Ravesteyn TW; Hoeksel J; Meijer GA; Te Riele H; van Leeuwen FE; Dinjens WN; van Leerdam ME Gut; 2018 Mar; 67(3):447-455. PubMed ID: 29439113 [TBL] [Abstract][Full Text] [Related]
19. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. Yurgelun MB; Kulke MH; Fuchs CS; Allen BA; Uno H; Hornick JL; Ukaegbu CI; Brais LK; McNamara PG; Mayer RJ; Schrag D; Meyerhardt JA; Ng K; Kidd J; Singh N; Hartman AR; Wenstrup RJ; Syngal S J Clin Oncol; 2017 Apr; 35(10):1086-1095. PubMed ID: 28135145 [TBL] [Abstract][Full Text] [Related]